Results 131 to 140 of about 13,391 (192)

GPSM2 Promotes Pancreatic Cancer Progression Through METTL3-Mediated m6A Modification of YAP1 mRNA. [PDF]

open access: yesJ Cell Mol Med
Xiu J   +9 more
europepmc   +1 more source

Diverse roles of YTHDC1 in chromatin and blood cancers. [PDF]

open access: yesFront Genet
Pernon B   +12 more
europepmc   +1 more source

MD simulations of METTL3/14

open access: yes
Chen, Shuang, Haider, Shozeb
openaire   +1 more source

m6A-Mediated epitranscriptional reprogramming drives cardiac fibrosis by suppressing PGC-1α and boosting mitochondrial fission. [PDF]

open access: yesJ Transl Med
Cao XY   +13 more
europepmc   +1 more source

The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification. [PDF]

open access: yesPLoS One
Sun H   +13 more
europepmc   +1 more source

The epitranscriptomic m6A RNA modification modulates the synapse in ageing and in a mouse model of synucleinopathy. [PDF]

open access: yesNPJ Parkinsons Dis
Chopra A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy